linkedin

Press Releases

Samsung BIO Insight

Unlocking the Possibilities to the Future of Biopharma | 2022 BIO International Convention

Unlocking the Possibilities to the Future of Biopharma


2022 BIO International Convention 

 

 

This year, the world’s largest biotech partnering event, BIO International Convention, was back in person for the first time since the COVID-19 pandemic. Samsung Biologics participated in the event from June 13-16 in San Diego, California, where it showcased its capabilities as a leading CDMO and actively met with potential clients for future projects. In line with the conference’s theme of “Limitless Together”, the event demonstrated a promising future of breakthrough innovations, paving the way for the next decade of biopharma.

 

 

Banner photo at the Bio International Convention in San Diego, USA1
Banner photo at the Bio International Convention in San Diego, USA2
Banner photo at the Bio International Convention in San Diego, USA3
Banner photo at the Bio International Convention in San Diego, USA4
Samsung Biologics booth view1 

 

     

Looking Towards The Next Frontier


Since its foundation in 2011, Samsung Biologics has participated in BIO every year and even when the conference moved online during the COVID-19 outbreak. As the pandemic enters its endemic phase, the company and biotech industry are now looking to what’s next in the latest trends and research.

 

"We are very excited to participate in the first face-to-face BIO International Convention in three years since the pandemic and to introduce our latest and innovative CDMO capabilities to clients,” said John Rim, CEO and President of Samsung Biologics. "We are continuously evolving to offer services for CDO, mRNA, and multi-modal products to further secure the success drivers for sustainable growth. We are also at the forefront in the biopharma industry to address critical issues like climate change as we aim to provide sustainable and enduring value for people worldwide and contribute to making the world a healthier place for all.”  

  

 

Interview with CEO John Lim1

Interview with CEO John Lim2

 

 

Driven. For a Sustainable Life.


Samsung Biologics presented its commitment to sustainability at the ESG section of the booth and showcased the company’s promise to become a “Green CDMO.” The company launched its new sustainability branding video, “Driven. For Sustainable Life.”, to mark the promise of building a healthier and sustainable future for all. 

 

 

Samsung Biologics booth view2


“With our aims to become a sustainable partner and a ‘Green CDMO’, we are actively investing in environment-conscious practices and technologies to mitigate the risks of climate change in the greater areas we impact,” said James Choi, EVP and Chief Information & Marketing Officer. “We are also working collaboratively on many global initiatives to help drive the net zero transition across the industry.”

 

 

Your Sustainable partner our journey to net zero
James Choi interview
  

Last year, Samsung Biologics joined together with leaders from global biopharma companies and public sector organizations including the WHO and Unicef, as part of the Sustainable Markets Initiative (SMI), convened by His Royal Highness The Prince of Wales, to accelerate the delivery of net zero and establish sustainable healthcare to improve individual, societal, and planetary health. 

 

“Samsung Biologics is also working at an industry-level to drive successful decarbonization,” Choi added. "We joined the Frontier 1.5D project to develop a climate risk management model, which affirms our commitment to shaping climate-resilient practices and policies across all value chains in the pharmaceutical and healthcare sectors.”

 

 

Addressing Key Insights into the Next Blockbuster


In addition to exhibition booths and networking receptions, over 100+ panel sessions covered various industry topics, such as next-generation biotherapeutics, mRNA, public policy, patient advocacy, and more. 

 

Pierre Catignol, Executive Vice President and Head of the Manufacturing Center, participated in a panel session to address key insights into mRNA and give guidance on what to look for in a CDMO partner.

 

During the session, Catignol introduced the unique capabilities of Samsung Biologics and how it offers fully integrated mRNA manufacturing services all at a single site in Songdo.

 

 

Samsung Biologics press conference

 

 

Limitless Together to Bring New Opportunities

 

interview

 

“BIO International is a place where bio-industry professionals and experts can come together to explore ways to cooperate and create new opportunities. This year’s theme of ‘Limitless Together’ is to show the cross-boundary collaboration of bio officials and the unlimited challenges in unknown areas,” said Adela Wilson from BIO. “Samsung Biologics’ performance was remarkable, both with its creative booth design and outstanding service competitiveness.”

 

 

waiting line
baja station
Samsung Biologics PR
bio concert

 

 

Samsung Biologics is at the forefront of building a sustainable future for all. By leveraging its world’s largest manufacturing capacity and continuous innovation, the company will strive to make innovative biologics accessible to all and create a healthier future. 

 

 

Samsung Biologics banner hanging on the airport road

 

 

Driven. For Life.

 

 

Related Contents

Samsung BIO Insight The Power of One I Samsung Biologics’ mRNA Capabilities

Life @ Samsung Biologics Driven. For Climate Action

 

Unlocking the Possibilities to the Future of Biopharma


2022 BIO International Convention 

 

 

This year, the world’s largest biotech partnering event, BIO International Convention, was back in person for the first time since the COVID-19 pandemic. Samsung Biologics participated in the event from June 13-16 in San Diego, California, where it showcased its capabilities as a leading CDMO and actively met with potential clients for future projects. In line with the conference’s theme of “Limitless Together”, the event demonstrated a promising future of breakthrough innovations, paving the way for the next decade of biopharma.

 

 

Banner photo at the Bio International Convention in San Diego, USA1
Banner photo at the Bio International Convention in San Diego, USA2
Banner photo at the Bio International Convention in San Diego, USA3
Banner photo at the Bio International Convention in San Diego, USA4
Samsung Biologics booth view1 

 

     

Looking Towards The Next Frontier


Since its foundation in 2011, Samsung Biologics has participated in BIO every year and even when the conference moved online during the COVID-19 outbreak. As the pandemic enters its endemic phase, the company and biotech industry are now looking to what’s next in the latest trends and research.

 

"We are very excited to participate in the first face-to-face BIO International Convention in three years since the pandemic and to introduce our latest and innovative CDMO capabilities to clients,” said John Rim, CEO and President of Samsung Biologics. "We are continuously evolving to offer services for CDO, mRNA, and multi-modal products to further secure the success drivers for sustainable growth. We are also at the forefront in the biopharma industry to address critical issues like climate change as we aim to provide sustainable and enduring value for people worldwide and contribute to making the world a healthier place for all.”  

  

 

Interview with CEO John Lim1

Interview with CEO John Lim2

 

 

Driven. For a Sustainable Life.


Samsung Biologics presented its commitment to sustainability at the ESG section of the booth and showcased the company’s promise to become a “Green CDMO.” The company launched its new sustainability branding video, “Driven. For Sustainable Life.”, to mark the promise of building a healthier and sustainable future for all. 

 

 

Samsung Biologics booth view2


“With our aims to become a sustainable partner and a ‘Green CDMO’, we are actively investing in environment-conscious practices and technologies to mitigate the risks of climate change in the greater areas we impact,” said James Choi, EVP and Chief Information & Marketing Officer. “We are also working collaboratively on many global initiatives to help drive the net zero transition across the industry.”

 

 

Your Sustainable partner our journey to net zero
James Choi interview
  

Last year, Samsung Biologics joined together with leaders from global biopharma companies and public sector organizations including the WHO and Unicef, as part of the Sustainable Markets Initiative (SMI), convened by His Royal Highness The Prince of Wales, to accelerate the delivery of net zero and establish sustainable healthcare to improve individual, societal, and planetary health. 

 

“Samsung Biologics is also working at an industry-level to drive successful decarbonization,” Choi added. "We joined the Frontier 1.5D project to develop a climate risk management model, which affirms our commitment to shaping climate-resilient practices and policies across all value chains in the pharmaceutical and healthcare sectors.”

 

 

Addressing Key Insights into the Next Blockbuster


In addition to exhibition booths and networking receptions, over 100+ panel sessions covered various industry topics, such as next-generation biotherapeutics, mRNA, public policy, patient advocacy, and more. 

 

Pierre Catignol, Executive Vice President and Head of the Manufacturing Center, participated in a panel session to address key insights into mRNA and give guidance on what to look for in a CDMO partner.

 

During the session, Catignol introduced the unique capabilities of Samsung Biologics and how it offers fully integrated mRNA manufacturing services all at a single site in Songdo.

 

 

Samsung Biologics press conference

 

 

Limitless Together to Bring New Opportunities

 

interview

 

“BIO International is a place where bio-industry professionals and experts can come together to explore ways to cooperate and create new opportunities. This year’s theme of ‘Limitless Together’ is to show the cross-boundary collaboration of bio officials and the unlimited challenges in unknown areas,” said Adela Wilson from BIO. “Samsung Biologics’ performance was remarkable, both with its creative booth design and outstanding service competitiveness.”

 

 

waiting line
baja station
Samsung Biologics PR
bio concert

 

 

Samsung Biologics is at the forefront of building a sustainable future for all. By leveraging its world’s largest manufacturing capacity and continuous innovation, the company will strive to make innovative biologics accessible to all and create a healthier future. 

 

 

Samsung Biologics banner hanging on the airport road

 

 

Driven. For Life.

 

 

Related Contents

Samsung BIO Insight The Power of One I Samsung Biologics’ mRNA Capabilities

Life @ Samsung Biologics Driven. For Climate Action

 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved